Home » Topics » Regulatory

Regulatory
RSS

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

FDA advisory committee recommends approval of injectable ziprasidone

Feb. 16, 2001

New oral formulation of Zomig approved by FDA

Feb. 15, 2001

Intramuscular formulation of Zyprexa clears hurdle on the way to FDA approval

Feb. 15, 2001

First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe

Feb. 12, 2001

Approvable letter issued by FDA for GlaxoSmithKline's Avandia in combination with insulin

Feb. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...